Literature DB >> 4037765

Treatment of central nervous system sarcoidosis with radiotherapy.

J M Bejar, G R Kerby, D K Ziegler, B W Festoff.   

Abstract

This report documents the twelve-year follow-up of a patient with neurosarcoidosis with multiple progressive central nervous system manifestations. Increased somnolence and seizure activity were associated with proliferation of nodular enhancing brain lesions, as seen on serial computed tomographic (CT) scans. Initially he responded to corticosteroid treatment, but gradually this response became unsatisfactory. After whole-brain irradiation with a total dose of 3,000 rads, his clinical symptoms improved with disappearance of the enhancing brain lesions seen on CT scan.

Entities:  

Mesh:

Year:  1985        PMID: 4037765     DOI: 10.1002/ana.410180214

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  6 in total

1.  Sarcoid meningitis, high adenosine deaminase levels in CSF and results of cranial irradiation.

Authors:  C Garcia-Moncó; J Berciano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

Review 2.  Sarcoidosis of the spinal cord: literature review and report of eight cases.

Authors:  Samer Saleh; Chandan Saw; Kamel Marzouk; Om Sharma
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

3.  Neurosarcoidosis.

Authors:  Aljoeson Walker; William Tyor
Journal:  Curr Treat Options Neurol       Date:  2001-11       Impact factor: 3.598

4.  Sarcoidosis of the anterior visual pathway: successes and failures.

Authors:  M J Gelwan; R I Kellen; R M Burde; M J Kupersmith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

5.  Neurosarcoidosis.

Authors:  Ashok V Patel; David E Stickler; William R Tyor
Journal:  Curr Treat Options Neurol       Date:  2007-05       Impact factor: 3.598

Review 6.  Endocrine aspects of neurosarcoidosis.

Authors:  G Murialdo; G Tamagno
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.